Brexpiprazole
Imran Qureshi, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Adjunctive treatment of
major depressive disorder
(MDD) in adults
Treatment of
schizophrenia
in adults and pediatric patients ages 13 years and older
Treatment of agitation associated with dementia due to
Alzheimer’s disease
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.